Ultrasound Assessment of Residual Gastric Content in Critically Ill Patients

Critically Ill Patients Clinical Trial

— GastrICU  

Official title:

Ultrasound Assessment of Residual Gastric Content in Critically Ill Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03205592
• Other study ID #: L16-174
• Status: Completed
• Start date: July 3, 2017
• Est. completion date: May 4, 2018

Study information

• Verified date: May 2018
• Source: Hôpital Edouard Herriot
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This prospective observational study aims to assess whether ultrasound assessment of gastric content may be useful for the monitoring of the gastric residual content in critically ill patients

Recruitment information / eligibility

• Status: Completed
• Enrollment: 61
• Est. completion date: May 4, 2018
• Est. primary completion date: May 4, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Critically ill patients under mechanical ventilation and enteral feeding through a gastric tube since >48 h

Exclusion Criteria:

• Digestive hemorrhage Contra-indication to prokinetic drugs Enteral feeding through jejunostomy or gastrostomy Pregnancy

Related Conditions & MeSH terms

• Critical Illness
• Critically Ill Patients

Intervention

Diagnostic Test:
• Ultrasound examination of the antrum
Ultrasound assessment of gastric content will be performed : prior to suction of gastric content through a gastric tube (method to assess the residual gastric content volume), after this suctioning of gastric content, then after reinjection of the content suctioned into the stomach (max 250 ml) and 1h30 later

Locations

Country	Name	City	State
France	Hôpital Nord	Marseille
France	Centre Hospitalier Lyon Sud	Pierre-Bénite
France	CHU Saint Etienne	Saint-Étienne

Sponsors (1)

Lead Sponsor	Collaborator
Hôpital Edouard Herriot

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	change in antral cross sectional area measured by ultrasonography after suctioning gastric volume	Ultrasound measurement of antral area and qualitative assessment	prior to and immediately after suctioning of gastric content volume through a gastric tube
Primary	Change in antral area after administration of prokinetic drug	If aspirated gastric content volume was > 250 ml, only 250 ml will be reinjected into the stomach and a prokientic drug will be administered (current protocol in our units). Antral area will be measured prior to and 90 min after the start of the infusion	Ultrasound assessment of gastric content after reinjection of suctioned gastric content and 1h30 later (1 h after the end of the infusion of prokinetic drug)